Today, Genenta Science S.p.A. disclosed a new financial maneuver involving a mandatory convertible bond agreement with ENEA Tech and Biomedical (ETB), securing €20 million in funding.

Genenta Science (Nasdaq: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, today announced a €20 million ($21.9 million) financing through the issuance of a Mandatory ...

Issuance follows an exchange offer to holders of its $150mln bond, which expires at the end of March following two extensions ...

Bank of New York Mellon Corp grew its stake in iShares Convertible Bond ETF (BATS:ICVT – Free Report) by 48.9% during the 4th ...

Genenta announced a EUR 20M financing through the issuance of a Mandatory Convertible Bond to ENEA Tech and Biomedical to support the expansion ...

HighTower Advisors LLC cut its stake in iShares Convertible Bond ETF (BATS:ICVT – Free Report) by 0.8% during the fourth ...

Convertible bonds start as low-interest debt instruments, but can turn into equities if the share prices they are tied to rise enough. The Chinese outperformance in this market largely mirrors their ...

General Atlantic is a co-investor in ProSieben's internet units - price comparison website Verivox, perfume e-retailer ...

ACV offers high current income and equity upside, outperforming traditional bonds in inflation-adjusted returns. Check out my ...